MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Instil Bio, Inc. (NQ:TIL)

8.900 -0.090 (-1.00%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 31,059
Open 9.000
Bid (Size) 7.700 (200)
Ask (Size) 9.150 (100)
Prev. Close 8.990
Today's Range 8.610 - 9.300
52wk Range 5.670 - 42.79
Shares Outstanding 128,761,873
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL
From Pomerantz LLP
Via GlobeNewswire
News headline image
CarMax Stock Down 47% This Past Year, But One Fund Is Betting $6 Million on a Turnaround ↗
CarMax runs a nationwide network of used car stores and digital channels, offering multi-channel sales and financing to U.S. consumers. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
-21.0%
-21.0%
1 Month
+23.6%
+23.6%
3 Month
-22.2%
-22.2%
6 Month
-69.5%
-69.5%
1 Year
-55.7%
-55.7%

More News

Read More
News headline image
Alumis Stock Has Rallied 250% This Past Year. One Fund Sold Its $5 Million Stake Last Quarter. ↗
Via The Motley Fool
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL
From Pomerantz LLP
Via GlobeNewswire
On Thursday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
Unusual volume stocks in Wednesday's session ↗
Via Chartmill
News headline image
Instil Bio Announces ImmuneOnco’s Presentation of ‘2510 Monotherapy Data in Patients with 2L+ Squamous NSCLC at the 2025 World Conference on Lung Cancer (WCLC)
From Instil Bio
Via GlobeNewswire
News headline image
Instil Bio Posts Wider Loss in Q2 ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Instil Bio Reports Second Quarter 2025 Financial Results and Provides Corporate Update
From Instil Bio
Via GlobeNewswire
News headline image
ImmuneOnco Announced Preliminary Safety & Efficacy Data from the Clinical Trial Studying IMM2510/AXN-2510, a PD-L1xVEGF Bispecific Antibody, in Combination with Chemotherapy in Front-line NSCLC in China
From Instil Bio
Via GlobeNewswire
News headline image
Here are the top movers in Monday's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
Instil Bio Announces U.S. F.D.A. Clearance of Investigational New Drug (IND) Application for AXN-2510, a PD-L1xVEGF Bispecific Antibody, for a Phase 1 Trial in Relapsed/Refractory Solid Tumors
From Instil Bio
Via GlobeNewswire
News headline image
Instil Bio Names John Maraganore, Ph.D., to Board Role Supporting the Advancement of PD-L1xVEGF Bispecific Antibody Program
From Instil Bio
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
News headline image
These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
These stocks that are showing activity before the opening bell on Monday. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
Instil Bio Announces Appointment of Jamie Freedman, M.D., Ph.D., as Chief Medical Officer
From Instil Bio
Via GlobeNewswire
News headline image
Instil Bio to Participate in the 2025 Jefferies Global Healthcare Conference
From Instil Bio
Via GlobeNewswire
News headline image
Instil Bio and ImmuneOnco to Host Investor and Analyst Breakfast to Discuss the Evolving PD-(L)1xVEGF Bispecific Antibody Landscape and Clinical Trial Updates During the 2025 ASCO Annual Meeting in Chicago
From Instil Bio
Via GlobeNewswire
News headline image
Keep an eye on the top gainers and losers in Thursday's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga

Frequently Asked Questions

Is Instil Bio, Inc. publicly traded?
Yes, Instil Bio, Inc. is publicly traded.
What exchange does Instil Bio, Inc. trade on?
Instil Bio, Inc. trades on the Nasdaq Stock Market
What is the ticker symbol for Instil Bio, Inc.?
The ticker symbol for Instil Bio, Inc. is TIL on the Nasdaq Stock Market
What is the current price of Instil Bio, Inc.?
The current price of Instil Bio, Inc. is 8.900
When was Instil Bio, Inc. last traded?
The last trade of Instil Bio, Inc. was at 02/27/26 04:00 PM ET
What is the market capitalization of Instil Bio, Inc.?
The market capitalization of Instil Bio, Inc. is 1.15B
How many shares of Instil Bio, Inc. are outstanding?
Instil Bio, Inc. has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story